Evidence map›Paper›PMID 34224205›Full record

ArticleTransboundary and emerging diseases2022

SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, Belgium.

Valeria Carolina Colombo, Vincent Sluydts, Joachim Mariën, Bram Vanden Broecke, Natalie Van Houtte, Wannes Leirs, Lotte Jacobs, Arne Iserbyt, Marine Hubert, Leo Heyndrickx and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Valeria Carolina ColomboEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.ORCID https://orcid.org/0000-0003-0439-7693
Vincent SluydtsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Joachim MariënEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Bram Vanden BroeckeEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Natalie Van HoutteEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Wannes LeirsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Lotte JacobsLaboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium.
Arne IserbytEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Marine HubertEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Leo HeyndrickxVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Hanne GorisEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Peter DelputteLaboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium.
Naomi De RoeckLaboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium.
Joris ElstEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Kevin K AriënVirology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Herwig LeirsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
Sophie GryseelsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEInstituut voor Tropische Geneeskunde · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 human-to-animal transmission can lead to the establishment of novel reservoirs and the evolution of new variants with the potential to start new outbreaks in humans. We tested Norway rats inhabiting the sewer system of Antwerp, Belgium, for the presence of SARS-CoV-2 following a local COVID-19 epidemic peak. In addition, we discuss the use and interpretation of SARS-CoV-2 serological tests on non-human samples. Between November and December 2020, Norway rat oral swabs, faeces and tissues from the sewer system of Antwerp were collected to be tested by RT-qPCR for the presence of SARS-CoV-2. Serum samples were screened for the presence of anti-SARS-CoV-2 IgG antibodies using a Luminex microsphere immunoassay (MIA). Samples considered positive were then checked for neutralizing antibodies using a conventional viral neutralization test (cVNT). The serum of 35 rats was tested by MIA showing three potentially positive sera that were later negative by cVNT. All tissue samples of 39 rats analysed tested negative for SARS-CoV-2 RNA. This is the first study that evaluates SARS-CoV-2 infection in urban rats. We can conclude that the sample of rats analysed had never been infected with SARS-CoV-2. However, monitoring activities should continue due to the emergence of new variants prone to infect Muridae rodents.

Indexed as

COVID-19AnimalsAntibodies, NeutralizingAntibodies, ViralBelgiumImmunoglobulin GRatsRNA, ViralSARS-CoV-2Antibodies, NeutralizingAntibodies, ViralImmunoglobulin GRNA, ViralBelgiumdisease outbreaksMuridaeratsSARS-CoV-2

Identifiers

PMID34224205
PMCPMC8447303
OpenAlexW3179934760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.